LGALS3 and heart failure: Of interest, the findings of the present study indicate a strong influence of cardiovascular risk factors on the prospective association between galectin-3 and diastolic dysfunction in T2DM, whereas comorbidities and heart failure medication intake seem to have a lower impact than CVRF.